Yoshinobu Kanda


Ontology type: schema:Person     


Person Info

NAME

Yoshinobu

SURNAME

Kanda

Publications in SciGraph latest 50 shown

  • 2022-05-10 Propensity score matching/reweighting analysis comparing autologous and allogeneic stem cell transplantation for B-lineage acute lymphoblastic leukemia in INTERNATIONAL JOURNAL OF HEMATOLOGY
  • 2022-04-16 Comparison of the impact of two post-remission therapy regimens on cardiac events in acute myeloid leukemia patients undergoing allogeneic hematopoietic stem cell transplantation in INTERNATIONAL JOURNAL OF HEMATOLOGY
  • 2022-04-11 Clinical interaction between dexamethasone and aprepitant in chemotherapy for lymphoma in ANNALS OF HEMATOLOGY
  • 2022-04-04 NPM1-mutation-based measurable residual disease assessment after completion of two courses of post-remission therapy is a valuable clinical predictor of the prognosis of acute myeloid leukemia in INTERNATIONAL JOURNAL OF HEMATOLOGY
  • 2022-03-24 Autologous hematopoietic cell transplantation for myeloma patients with hepatitis B virus or hepatitis C virus in the era of novel agents in BONE MARROW TRANSPLANTATION
  • 2022-03-21 Prognostic impact of chromosomal changes at relapse after allogeneic hematopoietic cell transplantation for acute myeloid leukemia or myelodysplastic syndrome in BONE MARROW TRANSPLANTATION
  • 2022-02-21 Correction to: Indications for fertility preservation not included in the 2017 Japan Society of Clinical Oncology Guideline for Fertility Preservation in Pediatric, Adolescent, and Young Adult Patients treated with gonadal toxicity, including benign diseases in INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY
  • 2022-02-11 Long-term follow-up of patients with paroxysmal nocturnal hemoglobinuria treated with eculizumab: post-marketing surveillance in Japan in INTERNATIONAL JOURNAL OF HEMATOLOGY
  • 2022-01-17 Disease-specific impact of anti-thymocyte globulin in allogeneic hematopoietic cell transplantation: a nationwide retrospective study on behalf of the JSTCT, transplant complications working group in BONE MARROW TRANSPLANTATION
  • 2022-01-06 Emergence of clone with PHF6 nonsense mutation in chronic myelomonocytic leukemia at relapse after allogeneic HCT in INTERNATIONAL JOURNAL OF HEMATOLOGY
  • 2021-11-17 Indications for fertility preservation not included in the 2017 Japan Society of Clinical Oncology Guideline for Fertility Preservation in Pediatric, Adolescent, and Young Adult Patients treated with gonadal toxicity, including benign diseases in INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY
  • 2021-10-13 Autologous hematopoietic cell transplantation during second or subsequent complete remission of acute promyelocytic leukemia: a prognostic factor analysis in BONE MARROW TRANSPLANTATION
  • 2021-10-11 Features of repertoire diversity and gene expression in human cytotoxic T cells following allogeneic hematopoietic cell transplantation in COMMUNICATIONS BIOLOGY
  • 2021-10-08 Outcomes of third allogeneic hematopoietic stem cell transplantation in relapsed/refractory acute leukemia after a second transplantation in BONE MARROW TRANSPLANTATION
  • 2021-10-03 Impact of chronic GVHD on QOL assessed by visual analogue scale in pediatric HSCT survivors and differences between raters: a cross-sectional observational study in Japan in INTERNATIONAL JOURNAL OF HEMATOLOGY
  • 2021-09-11 Nilotinib vs. imatinib in Japanese patients with newly diagnosed chronic myeloid leukemia in chronic phase: 10-year follow‑up of the Japanese subgroup of the randomized ENESTnd trial in INTERNATIONAL JOURNAL OF HEMATOLOGY
  • 2021-09-07 Cytomegalovirus reactivation is associated with an increased risk of late-onset invasive aspergillosis independently of grade II–IV acute graft-versus-host disease in allogeneic hematopoietic stem cell transplantation: JSTCT Transplant Complications Working Group in ANNALS OF HEMATOLOGY
  • 2021-09-07 Fludarabine/busulfan versus busulfan/cyclophosphamide as myeloablative conditioning for myelodysplastic syndrome: a propensity score-matched analysis in BONE MARROW TRANSPLANTATION
  • 2021-08-11 Chronic liver graft-versus-host disease in allogeneic hematopoietic stem cell transplantation recipients during tapering or after stopping calcineurin inhibitors in INTERNATIONAL JOURNAL OF HEMATOLOGY
  • 2021-08-06 Pre-conditioning intervention in patients with relapsed or refractory acute lymphoblastic leukemia who underwent allogeneic hematopoietic cell transplantation: a KSGCT multicenter retrospective analysis in ANNALS OF HEMATOLOGY
  • 2021-07-30 Newly proposed threshold and validation of white blood cell count at diagnosis for Philadelphia chromosome-positive acute lymphoblastic leukemia: risk assessment of relapse in patients with negative minimal residual disease at transplantation—a report from the Adult Acute Lymphoblastic Leukemia Working Group of the JSTCT in BONE MARROW TRANSPLANTATION
  • 2021-07-16 Prognostic value of measurable residual disease at allogeneic transplantation for adults with core binding factor acute myeloid leukemia in complete remission in BONE MARROW TRANSPLANTATION
  • 2021-06-25 Predictive and risk factor analysis for bloodstream infection in high-risk hematological patients with febrile neutropenia: post-hoc analysis from a prospective, large-scale clinical study in INTERNATIONAL JOURNAL OF HEMATOLOGY
  • 2021-06-21 Comparison of fludarabine, a myeloablative dose of busulfan, and melphalan vs conventional myeloablative conditioning regimen in patients with relapse and refractory acute myeloid leukemia in non-remission status in BONE MARROW TRANSPLANTATION
  • 2021-05-14 Impact of the combination of donor age and HLA disparity on the outcomes of unrelated bone marrow transplantation in BONE MARROW TRANSPLANTATION
  • 2021-04-19 Severe acute graft-versus-host disease increases the incidence of blood stream infection and mortality after allogeneic hematopoietic cell transplantation: Japanese transplant registry study in BONE MARROW TRANSPLANTATION
  • 2021-03-20 Risk factors for high-dose methotrexate-induced nephrotoxicity in INTERNATIONAL JOURNAL OF HEMATOLOGY
  • 2021-03-03 Does one model fit all? Predicting non-relapse mortality after allogeneic hematopoietic cell transplantation in BONE MARROW TRANSPLANTATION
  • 2021-02-11 Minimal residual disease (MRD) positivity at allogeneic hematopoietic cell transplantation, not the quantity of MRD, is a risk factor for relapse of Philadelphia chromosome-positive acute lymphoblastic leukemia in INTERNATIONAL JOURNAL OF HEMATOLOGY
  • 2021-01-08 Reduced leukemia relapse through cytomegalovirus reactivation in killer cell immunoglobulin-like receptor-ligand-mismatched cord blood transplantation in BONE MARROW TRANSPLANTATION
  • 2021-01-08 Stopping tyrosine kinase inhibitors started after allogeneic HCT in patients with Philadelphia chromosome-positive leukemia in BONE MARROW TRANSPLANTATION
  • 2020-12-02 Relapse of acute myeloid leukemia after allogeneic hematopoietic cell transplantation: clinical features and outcomes in BONE MARROW TRANSPLANTATION
  • 2020-11-09 Clinical association between thyroid disease and immune thrombocytopenia in ANNALS OF HEMATOLOGY
  • 2020-11-02 Identification of endoscopic factors that predict poor responses to steroids in patients with gastrointestinal acute graft-versus-host disease in BONE MARROW TRANSPLANTATION
  • 2020-10-20 Hematopoietic Stem Cell Transplantation in ENCYCLOPEDIA OF BEHAVIORAL MEDICINE
  • 2020-09-19 Long-term outcome in patients with Fanconi anemia who received hematopoietic stem cell transplantation: a retrospective nationwide analysis in INTERNATIONAL JOURNAL OF HEMATOLOGY
  • 2020-09-17 Effect of allogeneic HCT from unrelated donors in AML patients with intermediate- or poor-risk cytogenetics: a retrospective study from the Japanese Society for HCT in ANNALS OF HEMATOLOGY
  • 2020-09-05 Outcome of allogeneic hematopoietic stem cell transplantation in adult patients with paroxysmal nocturnal hemoglobinuria in INTERNATIONAL JOURNAL OF HEMATOLOGY
  • 2020-07-31 Allogeneic hematopoietic cell transplantation efficacy in patients with Philadelphia chromosome-positive acute myeloid leukemia in complete remission in BONE MARROW TRANSPLANTATION
  • 2020-07-29 Efficacy of combined orthokeratology and 0.01% atropine solution for slowing axial elongation in children with myopia: a 2-year randomised trial in SCIENTIFIC REPORTS
  • 2020-06-22 Factors that predict delayed platelet recovery after autologous stem cell transplantation for lymphoma or myeloma in ANNALS OF HEMATOLOGY
  • 2020-06-18 Real-world management of infection during chemotherapy for acute leukemia in Japan: from the results of a nationwide questionnaire-based survey by the Japan Adult Leukemia Study Group in INTERNATIONAL JOURNAL OF HEMATOLOGY
  • 2020-06-11 Impact of prednisolone dosage in the CHOP regimen for follicular lymphoma: a retrospective study in INTERNATIONAL JOURNAL OF HEMATOLOGY
  • 2020-05-23 Reduced-intensity conditioning is a reasonable alternative for Philadelphia chromosome-positive acute lymphoblastic leukemia among elderly patients who have achieved negative minimal residual disease: a report from the Adult Acute Lymphoblastic Leukemia Working Group of the JSHCT in BONE MARROW TRANSPLANTATION
  • 2020-03-23 Influence of HLA 1–3-locus mismatch and antithymocyte globulin administration in unrelated bone marrow transplantation in ANNALS OF HEMATOLOGY
  • 2020-03-20 Long-term results of reduced-intensity conditioning allogeneic hematopoietic cell transplantation for older patients with acute myeloid leukemia: a retrospective analysis of 10-year follow-up data in BONE MARROW TRANSPLANTATION
  • 2020-03-16 Impact of blood pressure early after allogeneic hematopoietic cell transplantation on clinical outcomes in ANNALS OF HEMATOLOGY
  • 2020-02-18 A prospective trial of vaccine to prevent hepatitis B virus reactivation after hematopoietic stem cell transplantation in BONE MARROW TRANSPLANTATION
  • 2020-02-12 Comparison of the outcomes after haploidentical and cord blood salvage transplantations for graft failure following allogeneic hematopoietic stem cell transplantation in BONE MARROW TRANSPLANTATION
  • 2019-12-18 Evaluation of thrombotic events in patients with immune thrombocytopenia in ANNALS OF HEMATOLOGY
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "affiliation": [
          {
            "affiliation": {
              "id": "http://www.grid.ac/institutes/grid.410804.9", 
              "type": "Organization"
            }, 
            "isCurrent": true, 
            "type": "OrganizationRole"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.412708.8", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.45203.30", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.26999.3d", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.415479.a", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.7597.c", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.415020.2", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.272242.3", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.415016.7", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.136593.b", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.410813.f", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.416093.9", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.39158.36", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.411248.a", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.410569.f", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.414932.9", 
            "type": "Organization"
          }
        ], 
        "familyName": "Kanda", 
        "givenName": "Yoshinobu", 
        "id": "sg:person.0617055140.49", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0617055140.49"
        ], 
        "sdDataset": "persons", 
        "sdDatePublished": "2022-06-01T22:53", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20220601/entities/gbq_results/person/person_978.jsonl", 
        "type": "Person"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/person.0617055140.49'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/person.0617055140.49'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/person.0617055140.49'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/person.0617055140.49'


     

    This table displays all metadata directly associated to this object as RDF triples.

    46 TRIPLES      10 PREDICATES      26 URIs      7 LITERALS      2 BLANK NODES

    Subject Predicate Object
    1 sg:person.0617055140.49 schema:affiliation Ncbe104ceab8c416abeb6198134283226
    2 grid-institutes:grid.136593.b
    3 grid-institutes:grid.26999.3d
    4 grid-institutes:grid.272242.3
    5 grid-institutes:grid.39158.36
    6 grid-institutes:grid.410569.f
    7 grid-institutes:grid.410813.f
    8 grid-institutes:grid.411248.a
    9 grid-institutes:grid.412708.8
    10 grid-institutes:grid.414932.9
    11 grid-institutes:grid.415016.7
    12 grid-institutes:grid.415020.2
    13 grid-institutes:grid.415479.a
    14 grid-institutes:grid.416093.9
    15 grid-institutes:grid.45203.30
    16 grid-institutes:grid.7597.c
    17 schema:familyName Kanda
    18 schema:givenName Yoshinobu
    19 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0617055140.49
    20 schema:sdDatePublished 2022-06-01T22:53
    21 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    22 schema:sdPublisher Nd565a63898144c09a7441c12a89beda5
    23 sgo:license sg:explorer/license/
    24 sgo:sdDataset persons
    25 rdf:type schema:Person
    26 Ncbe104ceab8c416abeb6198134283226 schema:affiliation grid-institutes:grid.410804.9
    27 sgo:isCurrent true
    28 rdf:type schema:OrganizationRole
    29 Nd565a63898144c09a7441c12a89beda5 schema:name Springer Nature - SN SciGraph project
    30 rdf:type schema:Organization
    31 grid-institutes:grid.136593.b schema:Organization
    32 grid-institutes:grid.26999.3d schema:Organization
    33 grid-institutes:grid.272242.3 schema:Organization
    34 grid-institutes:grid.39158.36 schema:Organization
    35 grid-institutes:grid.410569.f schema:Organization
    36 grid-institutes:grid.410804.9 schema:Organization
    37 grid-institutes:grid.410813.f schema:Organization
    38 grid-institutes:grid.411248.a schema:Organization
    39 grid-institutes:grid.412708.8 schema:Organization
    40 grid-institutes:grid.414932.9 schema:Organization
    41 grid-institutes:grid.415016.7 schema:Organization
    42 grid-institutes:grid.415020.2 schema:Organization
    43 grid-institutes:grid.415479.a schema:Organization
    44 grid-institutes:grid.416093.9 schema:Organization
    45 grid-institutes:grid.45203.30 schema:Organization
    46 grid-institutes:grid.7597.c schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...